Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (689) Lumigan (bimatoprost ophthalmic solution), Allergan,
...IOP of less than or equal to 17 mm Hg, whereas 37% of subjects receiving timolol twice daily, a leading drug used to lower IOP, achieved the same target pressure. At six months, Lumigan produced a 33% reduction in IOP compared to 23% with timolol (8.1 mm Hg vs. 5.6 mm Hg, respectively). Side Effects In clinical trials ...
View Page